—

ACORN CAPITAL ADVISORS, LLC

Q1 2026 13F Holdings

  • Location
    new york, NY
  • Num holdings

    22

  • Value ($000)

    $351,838

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0002054410
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
T
TERN

TERNS PHARMACEUTICALS INC

COM
880881107
$92.06M
26 %

1,746,264

C
CGON

CG ONCOLOGY INC

COM
156944100
$76.58M
22 %

1,130,501

---

UROGEN PHARMA LTD

COM
M96088105
$30.09M
9 %

1,673,420

P
PBYI

PUMA BIOTECHNOLOGY INC

COM
74587V107
$26.4M
8 %

4,131,299

---

TREVI THERAPEUTICS INC

COM
89532M101
$25.59M
7 %

2,144,844

C
CADL

CANDEL THERAPEUTICS INC

COM
137404109
$17.21M
5 %

3,497,948

---

BICARA THERAPEUTICS

COM
055477103
$12.8M
4 %

643,382

---

ONKURE THERAPEUTICS INC

CLASS A COM
68277Q105
$11.76M
3 %

2,839,674

---

JADE BIOSCEINCES INC

COM NEW
008064206
$11.05M
3 %

786,760

T
TARA

PROTARA THERAPEUTICS INC

COM STK
74365U107
$9.13M
3 %

1,752,115

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 22